首页> 外文期刊>Haematologica >Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML).Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT) | Haematologica
【24h】

Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML).Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT) | Haematologica

机译:欧洲骨髓移植(EBMT)小组重症再生障碍性贫血(WPSAA)工作组在非变性造血祖细胞(CML)中的非克隆性造血祖细胞的持久性血液学

获取原文
           

摘要

Normal and clonal hematopoietic progenitor cells have been demonstrated to coexist in chronic-phase chronic myelogenous leukemia (CML), but few data are available on the presence of non neoplastic hematopoiesis during the blastic transformation phase. We used reverse transcription-polymerase chain reaction (RT-PCR) to investigate expression of the BCR/ABL transcript of individual hematopoietic progenitors from a CML patient in blastic phase. We demonstrate that non clonal hematopoiesis is induced to re-emerge by conventional chemotherapy containing fludarabine. In addition, we confirm that some pluripotent CD34+/CD33-/DR- cells circulating in the peripheral blood are not clonal. Our data provide an encouraging basis for further studies of in vitro purification of normal hematopoietic stem cells in advanced stage CML and of their use in the context of autologous bone marrow transplantation.
机译:正常和克隆造血祖细胞已被证明可在慢性慢性粒细胞性白血病(CML)中共存,但在转化过程中非肿瘤性造血功能存在的数据很少。我们使用逆转录聚合酶链反应(RT-PCR)来研究来自CML患者处于发育期的单个造血祖细胞的BCR / ABL转录本的表达。我们证明了非克隆性造血作用是由含有氟达拉滨的常规化学疗法诱导重新出现的。此外,我们证实外周血中循环的一些多能CD34 + / CD33- / DR-细胞不是克隆的。我们的数据为进一步研究晚期CML正常造血干细胞及其在自体骨髓移植中的应用提供了令人鼓舞的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号